Aurobindo Pharma completed the acquisition of seven marketed oncology injectable products, intellectual property and commercial infrastructure from Spectrum Pharmaceuticals Inc, a US-based global branded oncology company by Acrotech Biopharma. Aurobindo will pay an upfront purchase price of $160 million in cash plus up to $140 million on achieving milestones.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2tLQLcg
Latest New Breaking News Today, National, World, Indian News Fast, English News Breaking, Latest English News, Breaking News, Read the Latest News On Business, Politics, Sports, Cream, Top Story, Cricket, Sports, Entertainment & Much More From India And Around The World, breaking news,city news,India news,international news,latest news,national news,world news,latest national news,breaking world news,trending news,current news,latest news India
No comments:
Post a Comment